MN1, a novel player in human AML

Blood Cells, Molecules, and Diseases

Volumn 39, Issue 3, 2007, Pages 336-339

  Grosveld, Gerard C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

CBF leukemia; Myeloid leukemia; Transcription coactivator

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CORE BINDING FACTOR; DIMER; GUANOSINE PHOSPHATE; HISTONE ACETYLTRANSFERASE PCAF; TRANSCRIPTION FACTOR ETV6;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW; CHROMOSOME 22; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; GENE OVEREXPRESSION; KARYOTYPE; MYELODYSPLASIA; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SUPPRESSOR GENE; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; HUMANS; LEUKEMIA, MYELOID, ACUTE; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 34748824109     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.06.009     Document Type: Review

References (26)

1. Lekanne Deprez R.H., Riegman P.H., Groen N.A., et al. Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma 8. Oncogene 10 (1995) 1521-1528
2. Buijs A., van Rompaey L., Molijn A.C., et al. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity 24. Mol. Cell. Biol. 20 (2000) 9281-9293
3. van Wely K.H., Molijn A.C., Buijs A., et al. The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription 5. Oncogene 22 (2003) 699-709
4. Chen Z., Fisher R.J., Riggs C.W., et al. Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides 10. Cancer Res. 57 (1997) 2013-2019
5. Eckner R., Ewen M.E., Newsome D., et al. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8 (1994) 869-884
6. 3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation 9. Mol. Endocrinol. 19 (2005) 2234-2244
7. Chen C.R., Kang Y., and Massague J. Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor beta growth arrest program 3. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 992-999
8. Kang Y., Chen C.R., and Massague J. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells 4. Mol. Cell 11 (2003) 915-926
9. Meester-Smoor M.A., Molijn A.C., Zhao Y., et al. The MN1 oncoprotein activates transcription of the IGFBP5 promoter through a CACCC-rich consensus sequence. J. Mol. Endocrinol. 38 (2007) 113-125
10. Buijs A., Sherr S., van Baal S., et al. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10 (1995) 1511-1519
11. Kawagoe H., and Grosveld G.C. Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9 13. Blood 106 (2005) 4269-4277
12. Kawagoe H., and Grosveld G.C. MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice 13. Blood 106 (2005) 4278-4286
13. Carella C., Potter M., Bonten J., et al. The ETS factor TEL2 is a hematopoietic oncoprotein 3. Blood 107 (2006) 1124-1132
14. Ross M.E., Mahfouz R., Onciu M., et al. Gene expression profiling of pediatric acute myelogenous leukemia 12. Blood 104 (2004) 3679-3687
15. Valk P.J., Verhaak R.G., Beijen M.A., et al. Prognostically useful gene-expression profiles in acute myeloid leukemia 16. N. Engl. J. Med. 350 (2004) 1617-1628
16. Liu P.P., Hajra A., Wijmenga C., and Collins F.S. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia 9. Blood 85 (1995) 2289-2302
17. Du Y., Jenkins N.A., and Copeland N.G. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 106 (2005) 3932-3939
18. Barjesteh van Waalwijk van Doorn-Khosrovani S., Erpelinck C., van Putten W.L., et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients 3. Blood 101 (2003) 837-845
19. Heuser M., Beutel G., Krauter J., et al. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood 108 (2006) 3898-3905
20. Carella C., Bonten J., Sirma S., et al. MN1 overexpression is an important step in the development of inv(16) AML. Leukemia (2007) (Electronic publication ahead of print, May 24)
21. Heuser M., Argiropoulos B., Kuchenbauer F., et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in AML patients. Blood (2007) (Electronic publication ahead of print, May 9)
22. Kuo Y.H., Landrette S.F., Heilman S.A., et al. Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia 1. Cancer Cell 9 (2006) 57-68
23. Meester-Smoor M.A., Vermeij M., van Helmond M.J., et al. Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton 10. Mol. Cell. Biol. 25 (2005) 4229-4236
24. O'Kelly J., Hisatake J., Hisatake Y., et al. Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J. Clin. Invest. 109 (2002) 1091-1099
25. Blobel G.A. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95 (2000) 745-755
26. Blobel G.A. CBP and p300: versatile coregulators with important roles in hematopoietic gene expression. J. Leukoc. Biol. 71 (2002) 545-556